Atlas Trials

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Clinical trial NCT02500511 · COMPLETED

Trial details

NCT number
NCT02500511
Sponsor
JN-International Medical Corporation
Status
COMPLETED
Study type
OBSERVATIONAL
Meningococcal MeningitisMeningococcal Infections
Start date
2015-06-01
Primary completion
2015-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.